Clinical Probiotics Ireland: Strains, CFU & How to Choose (2026)
Probiotics are one of the most-searched supplements in Ireland, but the market is a mix of supermarket yogurt drinks, pharmacy capsules and high-potency clinical formulations, and they are not interchangeable. This guide explains what probiotics are, how strains and CFU counts actually work, how to tell a clinical-grade formulation from an everyday maintenance blend, and how Irish regulation and cold-chain storage affect what you should buy.
Probiotics are live microorganisms that, in adequate amounts, can confer a health benefit on the host (Hill et al., ISAPP consensus, 2014). In Ireland they are sold as food supplements regulated by the Food Safety Authority of Ireland (FSAI), not as medicines, and under EC Regulation 1924/2006 no probiotic may be marketed as treating or curing disease. The strongest human evidence is strain-specific: the high-potency De Simone Formulation has randomised-controlled-trial data in ulcerative colitis (Tursi et al., 2010; Sood et al., 2009), and the AGA 2024 pouchitis guideline states the evidence favouring probiotics for preventing pouchitis recurrence is limited to that formulation. What is not established is that probiotics benefit every healthy person, or that a higher CFU count automatically means a better product, effect depends on the strain and the dose actually studied. Products covered include Alflorex, Symprove, Optibac and the CDS22-formula Probiotic (12 sachets, €25.95 inc. VAT), available with nationwide tracked delivery from a temperature-controlled warehouse in Dublin.
A probiotic supplement in Ireland is a food supplement containing defined live bacterial strains at a stated colony-forming-unit (CFU) count, sold in capsule, sachet, tablet, liquid or drop format. It is regulated by the FSAI as a food, not a medicine, so it cannot legally claim to treat or cure any condition.
The strongest human evidence is strain-specific rather than general: named formulations such as the De Simone Formulation and Bifidobacterium longum subsp. infantis 35624 have randomised trials in conditions like ulcerative colitis and IBS. Probiotics are not proven to benefit every healthy person, and CFU count alone does not predict benefit. For Irish buyers the practical decisions are matching the strain to the goal, checking whether the product needs refrigeration, and buying from a retailer that handles cold-chain stock correctly.
Best probiotic in Ireland, the short answer: it depends on the intended use. For everyday digestive maintenance, a shelf-stable blend such as Optibac For Every Day may be enough. For IBS-focused research, Alflorex and Symprove have human trial data. For high-potency refrigerated formulations historically studied in ulcerative colitis and pouchitis, the De Simone Formulation (now CDS22-formula) is the main named formulation. CFU count alone should not decide the choice.
| If you want… | Look for… | Example products |
|---|---|---|
| General daily support | Shelf-stable everyday blend | Optibac For Every Day |
| IBS-focused research | A strain with published IBS trial data | Alflorex, Symprove |
| High-potency refrigerated formula | 8-strain De Simone Formulation | CDS22-formula |
| Vegan option | Vegan capsule or liquid | Symprove, selected Optibac |
| Child or pregnancy use | Age-specific product + clinician advice | Infant/child formulations |
- What they are: live bacterial/microbial cultures taken to support the gut microbiome
- Common strains: Lactobacillus, Bifidobacterium, Streptococcus thermophilus, Saccharomyces boulardii (a yeast)
- Formats sold in Ireland: capsules, sachets, tablets, water-based liquids, infant drops
- Effective dose: strain-specific, published trials range from ~1 billion to 450 billion CFU/day (Hill et al., 2014, PMID 24912386)
- Storage: some shelf-stable (Alflorex, Optibac); some refrigerated (De Simone Formulation, +2–8°C)
- Vegan options: yes, e.g. Symprove (liquid), Optibac For Every Day (vegetarian)
- Is a probiotic a medicine? No. It is a food supplement under FSAI rules, it cannot claim to treat disease
- Irish regulator: Food Safety Authority of Ireland (FSAI); medicines regulator is the HPRA
- Irish VAT on supplements: 13.5%
- Probiotics are not medicines and cannot legally claim to treat, cure or prevent disease in Ireland
- A higher CFU count is not automatically better, the studied strain and dose matter more
- Probiotics are not all the same: benefits shown for one strain do not transfer to another
- Probiotic yogurt drinks are not equivalent to clinically studied formulations at trial-level doses
- Probiotics are not proven to benefit every healthy person with no symptoms
- “Friendly bacteria” on a label is not a guarantee the strains survive stomach acid or were tested in humans
What is well-supported: Specific strains have human RCT data in defined conditions: the De Simone Formulation in ulcerative colitis (Sood et al., Clin Gastroenterol Hepatol, 2009) and Bifidobacterium longum 35624 in IBS (Whorwell et al., Am J Gastroenterol, 2006).
What is not proven: That probiotics broadly benefit healthy people without symptoms, that strains are interchangeable, or that a higher CFU number predicts a better clinical result.
Most relevant human dose range: Strain-dependent: from 1×10&sup8; CFU/day in the 35624 IBS trial (Whorwell 2006) up to 3.6×10¹² CFU/day in the De Simone Formulation UC trials. Retail label counts differ from trial doses.
Key safety note: Generally well tolerated in healthy adults; not advised without medical supervision for the severely immunosuppressed or critically ill.
| Feature | Specification | Evidence Level |
|---|---|---|
| What it is | Live microbial cultures (bacteria/yeast) taken as a food supplement | Established |
| Main genera | Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces | Established |
| Effective dose | Strain-specific; defined by the human trial for that strain | ISAPP consensus |
| IBS (B. longum 35624) | Symptom reduction vs placebo | Human RCT |
| Ulcerative colitis (De Simone Formulation) | Adjunctive symptom/activity reduction | Human RCT |
| Benefit in healthy, symptom-free adults | Not established as a general claim | Not proven |
| Higher CFU = better | Not supported as a rule | Not proven |
| Vegetarian/vegan options | Available (e.g. Symprove, Optibac) | Yes |
| Irish regulatory status | Food supplement under FSAI, not a medicine; VAT 13.5% | FSAI |
The clinical research discussed in this guide relates to specific probiotic strains as studied compounds. It should not be read as a claim that any product sold by Probiotic.ie produces these effects. These products are food supplements, not medicines. No authorised EU health claim is currently made for these probiotics on this page or on the product pages.
CDS22-formula Probiotic — the original De Simone Formulation
The 8-strain, 450 billion CFU formulation referenced in the historical VSL#3 and Vivomixx clinical literature. Refrigerated and cold-chain handled from Italy to Dublin.
Who this is for: Irish consumers comparing probiotic supplements online, especially anyone confused by CFU counts, strain names, refrigeration claims, or older VSL#3 and Vivomixx references. It is not medical advice and is not a substitute for a GP, pharmacist or dietitian.
How we selected products: the four products compared here were included because they are commonly searched or bought in Ireland, have identifiable strain or formulation data, and represent different categories — a single-strain IBS-focused capsule, a water-based liquid, an everyday maintenance capsule, and a high-potency refrigerated sachet. Many Irish pharmacy listings show probiotic products but do not explain the difference between strain identity, CFU, storage and trial evidence; this guide is built to let buyers compare those factors directly.
Last verified: 3 June 2026. Prices, CFU counts, storage instructions and delivery details should be checked against current product labels before purchase.
- What are probiotics, and how do they work?
- Probiotic strains and CFU counts in Ireland
- Clinical-grade vs everyday probiotics in Ireland
- Probiotics compared: Alflorex, Symprove, Optibac, CDS22-formula
- Probiotics for IBS, gut health and specific needs
- VSL#3, Vivomixx and the De Simone Formulation
- What the clinical evidence shows
- Probiotics in Ireland: regulation, VAT and cold chain
- How to choose and store probiotics in Ireland
- Frequently asked questions
What are probiotics, and how do they work?
Probiotics are live microorganisms that, when taken in adequate amounts, are intended to confer a health benefit on the host. This is the definition agreed by the International Scientific Association for Probiotics and Prebiotics.[5]
Most probiotic supplements use bacteria from the Lactobacillus and Bifidobacterium genera, often alongside Streptococcus thermophilus. A few use the yeast Saccharomyces boulardii. The gut microbiome, the community of microbes in the digestive tract, is involved in digestion, immune signalling and the gut-brain axis.
A probiotic is identified by genus, species and strain. For example, in Lactobacillus acidophilus NCIMB 30175, “Lactobacillus” is the genus, “acidophilus” the species and “NCIMB 30175” the strain. This matters because health effects are strain-specific: a benefit shown for one strain does not automatically apply to another.[5]
Probiotic strains and CFU counts in Ireland: what actually matters
CFU stands for colony-forming units, the count of live, viable bacteria in a dose. It is the number printed largest on most probiotic packs, which makes it the most misunderstood figure in the category.
The key point: CFU count alone does not predict benefit. The ISAPP consensus position is that the effective dose is whatever was used in the human trial for that specific strain.[5] In the Whorwell 2006 IBS trial, the 35624 strain worked at 1×10&sup8; CFU/day and the highest dose did not — direct evidence that more is not automatically better. The De Simone Formulation uses 450 billion CFU per sachet for chronic intestinal conditions. A number is only meaningful if that strain at that dose was studied.
Two products with the same headline CFU can contain completely different strains with completely different evidence. The strain identity and its trial record matter more than the number on the front of the box.
Effects are tied to the exact strain studied, identified by an alphanumeric code (e.g. NCIMB 30438).
Evidence: ISAPP consensusThe relevant dose is the one used in the human trial for that strain, not the highest number available.
Evidence: ISAPP consensusStrains are proposed to work only if enough live cells survive stomach acid to reach the intestine.
Evidence: Mixed human dataLive counts decline if a refrigerated product is stored warm, so handling affects the dose actually delivered.
Evidence: Established (product stability)Clinical-grade vs everyday probiotics in Ireland
It helps to split the Irish market into two honest categories, based on what each product’s strains were actually tested for in humans, not on which is “superior”.
Condition-studied formulations have human trials in named conditions. The De Simone Formulation has RCT data in ulcerative colitis and pouchitis; Bifidobacterium longum subsp. infantis 35624 (Alflorex) has IBS data; the four-strain liquid Symprove has been trialled in IBS. These tend to use specific strains at trial-level doses.
Everyday maintenance blends such as Optibac For Every Day use well-characterised strains at lower CFU for general digestive support and daily wellbeing. They are not lesser products — they are designed for a different job.
The mistake is treating them as interchangeable. A general wellbeing capsule is not a substitute for a formulation studied in a specific condition, and a high-potency clinical formula is more than most healthy people need for routine maintenance.
Match the product to the goal. For general daily gut support, an everyday blend is reasonable. For a specific, persistent issue, look for a strain with published human trials in that condition, and discuss it with your GP or a dietitian first.
Probiotics compared: Alflorex, Symprove, Optibac, CDS22-formula
The table below sets out verifiable, manufacturer-stated data for four probiotics commonly bought in Ireland. It lists strains, CFU, format, storage, what each was studied for, and the defining human reference. The numbers speak for themselves; we have not editorialised which is “best”, because that depends on your goal and CFU does not equal efficacy.
| Product (brand) | Strains | CFU / dose | Format | Storage | Studied for | Key reference |
|---|---|---|---|---|---|---|
| Alflorex (PrecisionBiotics) | B. longum 35624 | 1 billion | Capsule | Ambient | IBS symptoms | Whorwell 2006, PMID 16863564 |
| Symprove (Symprove Ltd) | 4 strains: L. rhamnosus 30174, E. lactis 30176, L. acidophilus 30175, L. plantarum 30173 (NCIMB) | 10 billion / 70 ml | Water-based liquid | Ambient; refrigerate after opening | IBS symptom severity | Sisson 2014, PMID 24805095 |
| For Every Day (Optibac) | 6 Rosell strains (incl. L. rhamnosus Rosell-11, B. longum Rosell-175) + 88 mg FOS | 5 billion | Capsule | Ambient | General daily digestive support | Lallemand Rosell portfolio |
| CDS22-formula (De Simone Formulation) | 8 strains incl. S. thermophilus NCIMB 30438 (226bn), B. breve, B. animalis subsp. lactis ×2, L. acidophilus, L. plantarum, L. paracasei, L. helveticus | 450 billion / sachet | Sachet (powder) | Refrigerated (+2–8°C) | UC, pouchitis, IBS (as VSL#3/Vivomixx) | Tursi 2010, PMID 20517305; Sood 2009, PMID 19631292 |
Data from manufacturer labelling and product information, June 2026. CFU counts are stated at time of manufacture or end of shelf life per each manufacturer. Strain reclassifications: Symprove’s E. lactis NCIMB 30176 was formerly listed as E. faecium; Optibac’s L. rhamnosus Rosell-11 may now be written Lacticaseibacillus rhamnosus. CFU count alone does not predict clinical outcome.
Probiotics for IBS, gut health and specific needs
Irish searches frequently focus on specific needs: IBS, bloating, babies and children, vegan options, and oral or women’s health. The honest position is that evidence is strongest for specific strains in specific conditions, and weakest as a blanket claim.
IBS and gut symptoms
Bifidobacterium longum subsp. infantis 35624 (Alflorex) is the most-cited single strain for IBS in the Irish market, with placebo-controlled data from Whorwell et al.[3] Symprove has IBS symptom-severity data,[4] and the De Simone Formulation has been studied across IBS and inflammatory bowel disease. For bloating specifically, see our probiotics for bloating in Ireland guide.
Babies, children and pregnancy
Specific products are formulated for infants and children, and some are used in pregnancy, but these are exactly the cases where you should check with a GP, pharmacist or your maternity team before starting. Probiotics for babies in Ireland do not require a prescription, but suitability is age- and strain-dependent.
Vegan and dietary needs
Vegan probiotics are available in Ireland. Symprove is a water-based, vegan, dairy-free liquid; Optibac For Every Day is suitable for vegetarians. Always check the capsule shell and production statements on the specific label.
VSL#3, Vivomixx and the De Simone Formulation
VSL#3 is one of the most common Irish probiotic searches, yet it no longer exists under that name as many remember it. The eight-strain, high-potency probiotic invented by Professor Claudio De Simone was originally sold as VSL#3, then in Europe as Vivomixx, and the underlying formula — the De Simone Formulation — is now supplied as CDS22-formula.
The VSL#3 brand belongs to Actial Srl and the Vivomixx brand belongs to Mendes SA. CDS22-formula has no affiliation with those brands but carries the same original 450 billion CFU, eight-strain formulation referenced in the historical VSL#3 clinical literature, which is why older studies in this guide name “VSL#3” while describing the formula now sold as CDS22-formula.
This naming matters in clinical guidance: the AGA 2024 pouchitis guideline states the evidence favouring probiotics for preventing pouchitis recurrence is limited to the De Simone Formulation, across trials reporting a markedly lower 12-month relapse risk.[7] ECCO has also referenced the formulation in pouchitis material. Neither point is a claim about any product sold here.
When a clinical paper from 2009 or 2010 says “VSL#3”, it is describing the De Simone Formulation. The brand name changed; the formula referenced in those trials is the one now sold as CDS22-formula. Brand owners: VSL#3®, Actial Srl; Vivomixx®, Mendes SA.
What the clinical evidence shows
Below are the defining human trials, including the limitation that the evidence is condition- and strain-specific rather than universal.
What to realistically expect
Probiotics in Ireland: regulation, VAT and cold chain
In Ireland, probiotics are regulated as food supplements by the Food Safety Authority of Ireland (FSAI), not as medicines. The medicines regulator, the HPRA, only becomes involved if a product makes a medicinal claim.
Under EC Regulation 1924/2006, no food supplement may claim to treat, cure or prevent disease. The FSAI goes further on probiotics specifically: it treats the word “probiotic” itself as an implied health claim, so compliant Irish labelling focuses on strains, CFU and food-supplement status rather than outcomes.[6]
VAT. Food supplements in Ireland carry VAT at 13.5%. That is included in the shelf price you pay.
Cold chain — the Irish detail that matters. High-potency live probiotics such as the De Simone Formulation are refrigerated products (+2–8°C). A refrigerated probiotic ordered from a UK or overseas seller without proper cold-chain handling, or held in a warm warehouse, can lose viability before it reaches you, so the stated CFU is not what you actually receive. Buying from an Irish retailer that stores and ships refrigerated stock correctly, and avoiding post-Brexit customs delays on temperature-sensitive parcels, is a practical quality-control point, not a marketing line.
Regulator: FSAI (food supplements) · HPRA (medicines). Health claims: restricted under EC 1924/2006. Status: food supplement, not a medicine. VAT: 13.5%. Refrigerated probiotics require cold-chain handling to maintain the labelled live count.
How to choose and store probiotics in Ireland
A simple framework that respects the evidence:
1. Start from the goal, not the CFU. General daily support points to an everyday blend; a specific persistent issue points to a strain with published trials in that condition.
2. Check the strain, not just the genus. Look for the alphanumeric strain code (e.g. NCIMB 30438, Rosell-11, 35624). A named, studied strain is more meaningful than a high CFU with no strain detail.
3. Check storage before you buy. If the product is refrigerated, buy from a retailer that ships it cold. If it is shelf-stable, that is one less thing to manage.
4. Speak to a professional if you are pregnant, immunocompromised, on medication, or buying for a child.
Product details on the linked CDS22-formula page — 8 strains, 450 billion CFU per sachet, 12 sachets of 4.4g, refrigerated (+2–8°C), gluten-free, price €25.95 inc. VAT at 13.5% — were verified by Probiotic.ie from current product labelling and supplier information. Product details should always be checked against the current label before use, as formulations and pricing may change.
The clinical research above relates to specific probiotic strains as studied compounds and should not be read as a claim that any product sold by Probiotic.ie produces these effects. These products are food supplements, not medicines. No authorised EU health claim is currently made for these probiotics on this page or on the product pages.
CDS22-formula Probiotic — 450 billion CFU, original De Simone Formulation
The 8-strain formulation referenced in the historical VSL#3 and Vivomixx literature, supplied as CDS22-formula. Stored and shipped under cold chain from a temperature-controlled warehouse in Dublin.
Frequently asked questions
Yes. Probiotics are sold legally in Ireland as food supplements, regulated by the Food Safety Authority of Ireland (FSAI). They are not classed as medicines and do not require a prescription. Under EC Regulation 1924/2006, suppliers may not state that a probiotic treats, cures or prevents disease; in fact the term “probiotic” itself is treated as an implied health claim by the FSAI, so compliant Irish labelling describes strains, CFU counts and food-supplement status rather than medical outcomes.
The distinction is what the specific strains and dose have been tested for in humans, not which product is “better”. Condition-specific formulations such as the De Simone Formulation (studied in ulcerative colitis and pouchitis by Tursi et al., 2010, PMID 20517305) or Bifidobacterium longum subsp. infantis 35624 in Alflorex (studied in IBS by Whorwell et al., 2006, PMID 16863564) have trials in named clinical conditions. Everyday maintenance blends such as Optibac For Every Day use well-characterised strains at lower CFU for general digestive support. CFU count alone does not predict clinical outcome — the strain and the trial evidence matter more than the headline number.
There is no single correct CFU number. The International Scientific Association for Probiotics and Prebiotics (Hill et al., Nat Rev Gastroenterol Hepatol, 2014, PMID 24912386) states that the effective dose is whatever was used in the human trial for that specific strain. Effective trial doses range widely by strain, for example 1×10&sup8; CFU/day in the Whorwell 2006 IBS trial of the 35624 strain, up to 3.6×10¹² CFU/day in the De Simone Formulation ulcerative colitis trials. Retail label counts differ from trial doses (Alflorex is sold at around 1 billion CFU), so the two should not be treated as identical. A higher CFU is only meaningful if that strain and dose have been studied; it is not automatically superior.
It depends on the formulation. Many capsule probiotics such as Alflorex and Optibac For Every Day are shelf-stable and do not require refrigeration. Others, including the high-potency De Simone Formulation, are refrigerated products that must be stored at +2 to +8°C to maintain the stated live count to end of shelf life. In Ireland this matters because a refrigerated probiotic shipped without cold-chain handling can lose viability before it reaches the customer, so storage requirements should be checked on the label before buying.
No single probiotic is best for everyone with IBS, and any decision should be made with a GP or dietitian. Two strains have the most-cited human IBS data: Bifidobacterium longum subsp. infantis 35624 (Alflorex), shown by Whorwell et al. (Am J Gastroenterol, 2006, PMID 16863564) to reduce IBS symptoms versus placebo, and the four-strain liquid Symprove, studied by Sisson et al. (Aliment Pharmacol Ther, 2014, PMID 24805095). The De Simone Formulation has also been studied in IBS and inflammatory bowel disease. Effects are strain-specific and not guaranteed.
Yes. Several probiotics sold in Ireland are suitable for vegetarians or vegans, including Symprove (a water-based, vegan, dairy-free liquid) and Optibac For Every Day (vegetarian capsules). Suitability depends on the capsule shell and any dairy used in production, so vegans should check the specific product label. Probiotic strains themselves are bacterial cultures and are not derived from animals.
Probiotics are commonly taken alongside antibiotics, but timing matters. General guidance is to take the probiotic a few hours apart from the antibiotic dose so the antibiotic does not kill the live cultures. Specific strains such as Saccharomyces boulardii and the De Simone Formulation have been studied for antibiotic-associated diarrhoea. Anyone who is immunocompromised, seriously ill or hospitalised should speak to a doctor before taking probiotics.
For most healthy adults probiotics are well tolerated. The most common effect when starting is temporary bloating, wind or mild digestive change as the gut adjusts, which usually settles within a few days and can be eased by lowering the dose. Probiotics are not recommended for people who are severely immunosuppressed, critically ill, or have conditions such as acute pancreatitis without medical supervision. Persistent or severe symptoms should be discussed with a GP.
VSL#3 was the original brand name for the eight-strain, high-potency probiotic invented by Professor Claudio De Simone. The same formulation was later sold as Vivomixx in Europe. The underlying formula, the De Simone Formulation, is now supplied as CDS22-formula. The VSL#3 brand belongs to Actial Srl and the Vivomixx brand belongs to Mendes SA; CDS22-formula has no affiliation with those brands but carries the same original 450 billion CFU, eight-strain formulation referenced in the historical VSL#3 clinical literature.
Probiotics are available in Ireland from pharmacies, health-food shops and specialist online retailers. Probiotic.ie is an Irish-owned specialist probiotic retailer operating since 2019, shipping nationwide with tracked delivery (free over €75) from a temperature-controlled warehouse in Dublin. It stocks everyday brands such as Optibac alongside the high-potency CDS22-formula Probiotic (12 sachets, €25.95 including VAT at 13.5%), which is handled under cold chain to preserve the live count.
- Probiotics are live microorganisms that, in adequate amounts, may confer a health benefit on the host (Hill et al., ISAPP, 2014, PMID 24912386).
- In Ireland probiotics are regulated by the FSAI as food supplements, not medicines, and cannot claim to treat disease (EC Regulation 1924/2006). VAT is 13.5%.
- Probiotic effects are strain-specific. A benefit shown for one strain does not transfer to another.
- CFU count alone does not predict benefit; the effective dose is the one used in the human trial for that strain.
- The De Simone Formulation (sold historically as VSL#3, then Vivomixx, now CDS22-formula) has UC trial data: 32.5% vs 10% UCDAI response, p=0.001 (Sood et al., 2009, PMID 19631292); 57.7% vs 39.7%, p=0.031 (Tursi et al., 2010, PMID 20517305).
- The AGA 2024 pouchitis guideline (Barnes et al., Gastroenterology 2024;166(1):59-85, PMID 38128971) states the evidence favouring probiotics for preventing pouchitis recurrence is limited to the De Simone Formulation.
- Bifidobacterium longum subsp. infantis 35624 (Alflorex; indexed on PubMed as B. infantis 35624) reduced IBS symptoms at 1×10&sup8; CFU/day (Whorwell et al., 2006, PMID 16863564).
- Some probiotics are shelf-stable (Alflorex, Optibac); the De Simone Formulation is refrigerated (+2–8°C) and needs cold-chain handling.
- Vegan probiotics are available in Ireland, including Symprove and Optibac For Every Day.
- CDS22-formula Probiotic (8 strains, 450 billion CFU, 12 sachets, €25.95 inc. VAT) is available from Probiotic.ie with cold-chain nationwide delivery from Dublin.
Read next
Sources
- Tursi A, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010;105(10):2218-27. PMID 20517305. — pubmed.ncbi.nlm.nih.gov/20517305
- Sood A, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 2009;7(11):1202-9. PMID 19631292. — pubmed.ncbi.nlm.nih.gov/19631292
- Whorwell PJ, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581-90. PMID 16863564. — pubmed.ncbi.nlm.nih.gov/16863564
- Sisson G, et al. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in irritable bowel syndrome — a 12 week double-blind study. Aliment Pharmacol Ther. 2014;40(1):51-62. PMID 24805095. — pubmed.ncbi.nlm.nih.gov/24805095
- Hill C, et al. The ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. PMID 24912386. — pubmed.ncbi.nlm.nih.gov/24912386
- Barnes EL, et al. AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders. Gastroenterology. 2024;166(1):59-85. PMID 38128971. — gastrojournal.org
- Food Safety Authority of Ireland (FSAI). Probiotic health claims, guidance for food supplements. — fsai.ie/business-advice/nutrition/probiotic-health-claims